Cite
ANXA3 as a novel biomarker for sepsis diagnosis: Evidence from integrative WGCNA analysis
MLA
Jing-Xiang Zhang, et al. “ANXA3 as a Novel Biomarker for Sepsis Diagnosis: Evidence from Integrative WGCNA Analysis.” Heliyon, vol. 10, no. 19, Oct. 2024. EBSCOhost, https://doi.org/10.1016/j.heliyon.2024.e38608.
APA
Jing-Xiang Zhang, Xin-Hao Xing, Ren-Yi Lu, Meng-Xiao Liu, Wei-Heng Xu, Hao-Cheng Zhang, Qing-Jie Zhao, & Yan Wang. (2024). ANXA3 as a novel biomarker for sepsis diagnosis: Evidence from integrative WGCNA analysis. Heliyon, 10(19). https://doi.org/10.1016/j.heliyon.2024.e38608
Chicago
Jing-Xiang Zhang, Xin-Hao Xing, Ren-Yi Lu, Meng-Xiao Liu, Wei-Heng Xu, Hao-Cheng Zhang, Qing-Jie Zhao, and Yan Wang. 2024. “ANXA3 as a Novel Biomarker for Sepsis Diagnosis: Evidence from Integrative WGCNA Analysis.” Heliyon 10 (19). doi:10.1016/j.heliyon.2024.e38608.